Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 7/2010

Open Access 01-07-2010 | REVIEW ARTICLE

Contemporary management of cancer of the oral cavity

Authors: Eric M. Genden, Alfio Ferlito, Carl E. Silver, Robert P. Takes, Carlos Suárez, Randall P. Owen, Missak Haigentz Jr., Sandro J. Stoeckli, Ashok R. Shaha, Alexander D. Rapidis, Juan Pablo Rodrigo, Alessandra Rinaldo

Published in: European Archives of Oto-Rhino-Laryngology | Issue 7/2010

Login to get access

Abstract

Oral cancer represents a common entity comprising a third of all head and neck malignant tumors. The options for curative treatment of oral cavity cancer have not changed significantly in the last three decades; however, the work up, the approach to surveillance, and the options for reconstruction have evolved significantly. Because of the profound functional and cosmetic importance of the oral cavity, management of oral cavity cancers requires a thorough understanding of disease progression, approaches to management and options for reconstruction. The purpose of this review is to discuss the most current management options for oral cavity cancers.
Literature
1.
Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758PubMedCrossRef
2.
de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP (2010) Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck (in press)
3.
Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wünsch-Filho V, Franceschi S, Hayes RB, Herrero R, Kelsey K, Koifman S, La Vecchia C, Lazarus P, Levi F, Lence JJ, Mates D, Matos E, Menezes A, McClean MD, Muscat J, Eluf-Neto J, Olshan AF, Purdue M, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Shangina O, Pilarska A, Zhang ZF, Ferro G, Berthiller J, Boffetta P (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18:541–550PubMedCrossRef
4.
Hennessey PT, Westra WH, Califano JA (2009) Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res 88:300–306PubMedCrossRef
5.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papilloma virus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612–619PubMedCrossRef
6.
Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121:2465–2472PubMedCrossRef
7.
Sikora AG, Morris LG, Sturgis EM (2009) Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg 135:402–405PubMedCrossRef
8.
Velly AM, Franco EL, Schlecht N, Pintos J, Kowalski LP, Oliveira BV, Curado MP (1998) Relationship between dental factors and risk of upper aerodigestive tract cancer. Oral Oncol 34:284–291PubMed
9.
Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS (2009) Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45:324–334PubMedCrossRef
10.
Ho T, Wei Q, Sturgis EM (2007) Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck 29:682–699PubMedCrossRef
11.
Rapidis AD, Gullane P, Langdon JD, Lefebvre JL, Scully C, Shah JP (2009) Major advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancer. Oral Oncol 45:299–300PubMedCrossRef
12.
Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP, Lam WL (2009) Genomic imbalances in precancerous tissues signal oral cancer risk. Mol Cancer 23:8–50
13.
Fleskens S, Slootweg P (2009) Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility. Head Neck Oncol 1:11PubMedCrossRef
14.
Waldron CA, Shafer WG (1975) Leukoplakia revisited: a clinicopathologic study 3256 oral leukoplakias. Cancer 36:1386–1392PubMedCrossRef
15.
Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M Jr, Suárez C, Vander Poorten V, Hermans R, Rodrigo JP, Devaney KO, Ferlito A (2010) The future of the TNM classification and staging system in head and neck cancer. Head Neck (in press)
16.
Yuen AP, Lam KY, Wei WI, Lam KY, Ho CM, Chow TL, Yuen WF (2000) A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am J Surg 180:139–143PubMedCrossRef
17.
Asakage T, Yokose T, Mukai K, Tsugane S, Tsubono Y, Asai M, Ebihara S (1998) Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer 82:1443–1448PubMedCrossRef
18.
Fukano H, Matsuura H, Hasegawa Y, Nakamura S (1997) Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 19:205–210PubMedCrossRef
19.
Patel RS, Clark JR, Dirven R, Wyten R, Gao K, O’Brien CJ (2009) Prognostic factors in the surgical treatment of patients with oral carcinoma. ANZ J Surg 79:19–22PubMedCrossRef
20.
Ambrosch P, Brinck U (1996) Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Williston Park) 10:1221–1226
21.
Goerkem M, Braun J, Stoeckli SJ (2010) Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinomas of the oral cavity. Ann Surg Oncol (in press)
22.
Bilde A, von Buchwald C, Therkildsen MH, Mortensen J, Kirkegaard J, Charabi B, Specht L (2008) Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope 118:408–414PubMedCrossRef
23.
Alkureishi LW, Ross GL, Shoaib T, Soutar DS, Robertson AG, Sorensen JA, Thomsen J, Krogdahl A, Alvarez J, Barbier L, Santamaria J, Poli T, Sesenna E, Kovács AF, Grünwald F, Barzan L, Sulfaro S, Alberti F (2008) Does tumor depth affect nodal upstaging in squamous cell carcinoma of the head and neck? Laryngoscope 118:629–634PubMedCrossRef
24.
Alvi A, Johnson JT (1996) Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 114:65–70PubMedCrossRef
25.
Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, Myers JN (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97:1464–1470PubMedCrossRef
26.
Ferlito A, Rinaldo A, Devaney KO, MacLennan K, Myers JN, Petruzzelli GJ, Shaha AR, Genden EM, Johnson JT, de Carvalho MB, Myers EN (2002) Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol 38:747–751PubMedCrossRef
27.
Woolgar JA, Vaughan ED, Scott J, Brown JS (1994) Pathological findings in clinically false-negative and false-positive neck dissections for oral carcinoma. Ann R Coll Surg Engl 76:237–244PubMed
28.
Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29:167–178PubMedCrossRef
29.
Poate TW, Buchanan JA, Hodgson TA, Speight PM, Barrett AW, Moles DR, Scully C, Porter SR (2004) An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 40:829–834PubMedCrossRef
30.
Svirsky JA, Burns JC, Carpenter WM, Cohen DM, Bhattacharyya I, Fantasia JE, Lederman DA, Lynch DP, Sciubba JJ, Zunt SL (2002) Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 50:500–503PubMed
31.
Upile T, Jerjes W, Sterenborg HJ, El-Naggar AK, Sandison A, Witjes MJ, Biel MA, Bigio I, Wong BJ, Gillenwater A, Macrobert AJ, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Mosse CA, Barr H, Chen Z, Berg K, D’Cruz AK, Stone N, Kendall C, Fisher S, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Yodh AG, Hopper C (2009) Head and neck optical diagnostics: vision of the future of surgery. Head Neck Oncol 1:25PubMedCrossRef
32.
Leslie A, Fyfe E, Guest P, Goddard P, Kabala JE (1999) Staging of squamous cell carcinoma of the oral cavity and oropharynx: a comparison of MRI and CT in T- and N-staging. J Comput Assist Tomogr 23:43–49PubMedCrossRef
33.
van den Brekel MW, Runne RW, Smeele LE, Tiwari RM, Snow GB, Castelijns JA (1998) Assessment of tumour invasion into the mandible: the value of different imaging techniques. Eur Radiol 8:1552–1557PubMedCrossRef
34.
Imola MJ, Gapany M, Grund F, Djalilian H, Fehling S, Adams G (2001) Technetium 99m single positron emission computed tomography scanning for assessing mandible invasion in oral cavity cancer. Laryngoscope 111:373–381PubMedCrossRef
35.
Lane AP, Buckmire RA, Mukherji SK, Pillsbury HC 3rd, Meredith SD (2000) Use of computed tomography in the assessment of mandibular invasion in carcinoma of the retromolar trigone. Otolaryngol Head Neck Surg 122:673–677PubMedCrossRef
36.
Brockenbrough JM, Petruzzelli GJ, Lomasney L (2003) DentaScan as an accurate method of predicting mandibular invasion in patients with squamous cell carcinoma of the oral cavity. Arch Otolaryngol Head Neck Surg 129:113–117PubMedCrossRef
37.
Tsue TT, McCulloch TM, Girod DA, Couper DJ, Weymuller EA Jr, Glenn MG (1994) Predictors of carcinomatous invasion of the mandible. Head Neck 16:116–126PubMedCrossRef
38.
Shaha AR (1991) Preoperative evaluation of the mandible in patients with carcinoma of the floor of mouth. Head Neck 13:398–402PubMedCrossRef
39.
Van Cann EM, Koole R, Oyen WJ, de Rooy JW, de Wilde PC, Slootweg PJ, Schipper M, Merkx MA, Stoelinga PJ (2008) Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. Int J Oral Maxillofac Surg 37:535–541PubMedCrossRef
40.
Pandey M, Rao LP, Das SR (2009) Predictors of mandibular involvement in cancers of the oromandibular region. J Oral Maxillofac Surg 67:1069–1073PubMedCrossRef
41.
Shaw RJ, Brown JS, Woolgar JA, Lowe D, Rogers SN, Vaughan ED (2004) The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head Neck 26:861–869PubMedCrossRef
42.
Brown JS, Lowe D, Kalavrezos N, D’Souza J, Magennis P, Woolgar J (2002) Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma. Head Neck 24:370–383PubMedCrossRef
43.
Brown JS, Lewis-Jones H (2001) Evidence for imaging the mandible in the management of oral squamous cell carcinoma: a review. Br J Oral Maxillofac Surg 39:411–418PubMedCrossRef
44.
van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB (1993) Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 250:11–17PubMedCrossRef
45.
Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ (1998) Comparison of CT and MR imaging in staging of neck metastases. Radiology 207:123–130PubMed
46.
Atula TS, Varpula MJ, Kurki TJ, Klemi PJ, Grénman R (1997) Assessment of cervical lymph node status in head and neck cancer patients: palpation, computed tomography and low field magnetic resonance imaging compared with ultrasound-guided fine-needle aspiration cytology. Eur J Radiol 25:152–161PubMedCrossRef
47.
Takes RP, Righi P, Meeuwis CA, Manni JJ, Knegt P, Marres HA, Spoelstra HA, de Boer MF, van der Mey AG, Bruaset I, Ball V, Weisberger E, Radpour S, Kruyt RH, Joosten FB, Laméris JS, van Oostayen JA, Kopecky K, Caldemeyer K, Henzen-Logmans SC, Wiersma-van Tilburg JM, Bosman FT, van Krieken JH, Hermans J, Baatenburg de Jong RJ (1998) The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys 40:1027–1032PubMed
48.
Baatenburg de Jong RJ, Rongen RJ, Verwoerd CD, van Overhagen H, Laméris JS, Knegt P (1991) Ultrasound-guided fine-needle aspiration biopsy of neck nodes. Arch Otolaryngol Head Neck Surg 117:402–404PubMed
49.
Braams JW, Pruim J, Nikkels PG, Roodenburg JL, Vaalburg W, Vermey A (1996) Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT. J Nucl Med 37:897–901PubMed
50.
Stuckensen T, Kovács AF, Adams S, Baum RP (2000) Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 28:319–324PubMed
51.
Branstetter BF 4th, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, Meltzer CC (2005) Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 235:580–586PubMedCrossRef
52.
Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2007) Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol 43:887–893PubMedCrossRef
53.
Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U, Westhofen M (2000) Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 126:1457–1461PubMed
54.
Pohar S, Brown R, Newman N, Koniarczyk M, Hsu J, Feiglin D (2007) What does PET imaging add to conventional staging of head and neck cancer patients? Int J Radiat Oncol Biol Phys 68:383–387PubMed
55.
Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ (2006) 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47:755–762PubMed
56.
Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT (2006) Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 24:4371–4376PubMedCrossRef
57.
Brouwer J, de Bree R, Comans EF, Castelijns JA, Hoekstra OS, Leemans CR (2004) Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol 261:479–483PubMedCrossRef
58.
Stoeckli SJ, Steinert H, Pfaltz M, Schmid S (2002) Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24:345–349PubMedCrossRef
59.
60.
Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A (2006) Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 16:1468–1477PubMedCrossRef
61.
Fischbein NJ, Noworolski SM, Henry RG, Kaplan MJ, Dillon WP, Nelson SJ (2003) Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 24:301–311PubMed
62.
Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ (2002) Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222:239–244PubMedCrossRef
63.
Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM (2003) Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228:777–788PubMedCrossRef
64.
Sigal R, Vogl T, Casselman J, Moulin G, Veillon F, Hermans R, Dubrulle F, Viala J, Bosq J, Mack M, Depondt M, Mattelaer C, Petit P, Champsaur P, Riehm S, Dadashitazehozi Y, de Jaegere T, Marchal G, Chevalier D, Lemaitre L, Kubiak C, Helmberger R, Halimi P (2002) Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR)—results of a phase-III multicenter clinical trial. Eur Radiol 12:1104–1113PubMedCrossRef
65.
Viet CT, Schmidt BL (2008) Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev 17:3603–3611PubMedCrossRef
66.
Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT (2008) Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14:6246–6252PubMedCrossRef
67.
Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM, Mao L (2008) Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol 26:354–360PubMedCrossRef
68.
Torres-Rendon A, Stewart R, Craig GT, Wells M, Speight PM (2009) DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncol 45:468–473PubMedCrossRef
69.
Bremmer JF, Braakhuis BJ, Brink A, Broeckaert MA, Beliën JA, Meijer GA, Kuik DJ, Leemans CR, Bloemena E, van der Waal I, Brakenhoff RH (2008) Comparative evaluation of genetic assays to identify oral pre-cancerous fields. J Oral Pathol Med 37:599–606PubMedCrossRef
70.
Matta A, Tripathi SC, DeSouza LV, Grigull J, Kaur J, Chauhan SS, Srivastava A, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Michael Siu KW (2009) Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer 125:1398–1406PubMedCrossRef
71.
Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E, Wong DT (2006) Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24:1754–1760PubMedCrossRef
72.
Matta A, DeSouza LV, Shukla NK, Gupta SD, Ralhan R, Siu KW (2008) Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 7:2078–2087PubMedCrossRef
73.
Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM (2009) Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 217:516–523PubMedCrossRef
74.
Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, Patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B (2009) Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 9:11PubMedCrossRef
75.
Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, Tilanus MG, Koole R, Hordijk GJ, van der Vliet PC, Reinders MJ, Slootweg PJ, Holstege FC (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37:182–186PubMedCrossRef
76.
Nyst HJ, Tan IB, Stewart FA, Balm AJ (2009) Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? Photodiagnosis Photodyn Ther 6:3–11PubMedCrossRef
77.
de Bree R, Rinaldo A, Genden EM, Suárez C, Rodrigo JP, Fagan JJ, Kowalski LP, Ferlito A, Leemans CR (2008) Modern reconstruction techniques for oral and pharyngeal defects after tumor resection. Eur Arch Otorhinolaryngol 265:1–9PubMedCrossRef
78.
Klug C, Berzaczy D, Voracek M, Millesi W (2008) Preoperative chemoradiotherapy in the management of oral cancer: a review. J Craniomaxillofac Surg 36:75–88PubMed
79.
Robbins KT, Samant S, Vieira F, Kumar P (2004) Presurgical cytoreduction of oral cancer using intra-arterial cisplatin and limited concomitant radiation therapy (Neo-RADPLAT). Arch Otolaryngol Head Neck Surg 130:28–32PubMedCrossRef
80.
Cohen EE, Baru J, Huo D, Haraf DJ, Crowley M, Witt ME, Blair EA, Weichselbaum RR, Rosen F, Vokes EE, Stenson K (2009) Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head Neck 31:1013–1021PubMedCrossRef
81.
Kreeft A, Tan IB, van den Brekel MW, Hilgers FJ, Balm AJ (2009) The surgical dilemma of ‘functional inoperability’ in oral and oropharyngeal cancer: current consensus on operability with regard to functional results. Clin Otolaryngol 34:140–146PubMedCrossRef
82.
Beitler JJ, Smith RV, Silver CE, Quish A, Deore SM, Mullokandov E, Fontenla DP, Wadler S, Hayes MK, Vikram B (1998) Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radiat Oncol Biol Phys 40:313–317PubMed
83.
Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu K, Radiation Therapy Oncology Group 9501/Intergroup (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944PubMedCrossRef
84.
Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M, European Organization for Research and Treatment of Cancer Trial 22931 (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952PubMedCrossRef
85.
Wong RJ, Keel SB, Glynn RJ, Varvares MA (2000) Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope 110:65–72PubMedCrossRef
86.
Werning JW, Byers RM, Novas MA, Roberts D (2001) Preoperative assessment for and outcomes of mandibular conservation surgery. Head Neck 23:1024–1030PubMedCrossRef
87.
Holmstrup P, Thorn JJ, Rindum J, Pindborg JJ (1988) Malignant development of lichen planus-affected oral mucosa. J Oral Pathol 17:219–225PubMedCrossRef
88.
Vegers JW, Snow GB, van der Waal I (1979) Squamous cell carcinoma of the buccal mucosa: a review of 85 cases. Arch Otolaryngol 105:192–195PubMed
89.
Sessions DG, Spector GJ, Lenox J, Parriott S, Haughey B, Chao C, Marks J, Perez C (2000) Analysis of treatment results for floor-of-mouth cancer. Laryngoscope 110:1764–1772PubMedCrossRef
90.
McGuirt WF Jr, Johnson JT, Myers EN, Rothfield R, Wagner R (1995) Floor of mouth carcinoma: the management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 121:278–282PubMed
91.
Hicks WL Jr, Loree TR, Garcia RI, Maamoun S, Marshall D, Orner JB, Bakamjian VY, Shedd DP (1997) Squamous cell carcinoma of the floor of mouth: a 20-year review. Head Neck 19:400–405PubMedCrossRef
92.
Cordeiro PG, Disa JJ, Hidalgo DA, Hu QY (1999) Reconstruction of the mandible with osseous free flaps: a 10-year experience with 150 consecutive patients. Plast Reconstr Surg 104:1314–1320PubMedCrossRef
93.
Schrag C, Chang YM, Tsai CY, Wei FC (2006) Complete rehabilitation of the mandible following segmental resection. J Surg Oncol 94:538–545PubMedCrossRef
94.
van Gemert JT, van Es RJ, Van Cann EM, Koole R (2009) Nonvascularized bone grafts for segmental reconstruction of the mandible—a reappraisal. J Oral Maxillofac Surg 67:1446–1452PubMedCrossRef
95.
Yousif NJ, Dzwierzynski WW, Sanger JR, Matloub HS, Campbell BH (1999) The innervated gracilis musculocutaneous flap for total tongue reconstruction. Plast Reconstr Surg 104:916–921PubMedCrossRef
96.
Sharma M, Iyer S, Kuriakose MA, Vijayaraghavan S, Arun P, Sudhir VR, Chatni SS, Sharan R (2009) Functional reconstruction of near total glossectomy defects using composite gastro omental-dynamic gracilis flaps. J Plast Reconstr Aesthet Surg 62:1277–1280PubMedCrossRef
97.
Hanasono MM, Weinstock YE, Yu P (2008) Reconstruction of extensive head and neck defects with multiple simultaneous free flaps. Plast Reconstr Surg 122:1739–1746PubMedCrossRef
98.
Siemionow M, Papay F, Alam D, Bernard S, Djohan R, Gordon C, Hendrickson M, Lohman R, Eghtesad B, Coffman K, Kodish E, Paradis C, Avery R, Fung J (2009) Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 374:203–209PubMedCrossRef
99.
Capote A, Escorial V, Muñoz-Guerra MF, Rodríguez-Campo FJ, Gamallo C, Naval L (2007) Elective neck dissection in early-stage oral squamous cell carcinoma—does it influence recurrence and survival? Head Neck 29:3–11PubMedCrossRef
100.
Ferlito A, Shaha AR, Rinaldo A (2002) The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol 38:3–5PubMedCrossRef
101.
Ferlito A, Rinaldo A, Devaney KO, Nakashiro K, Hamakawa H (2008) Detection of lymph node micrometastases in patients with squamous carcinoma of the head and neck. Eur Arch Otorhinolaryngol 265:1147–1153PubMedCrossRef
102.
Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P (1997) Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 19:14–19PubMedCrossRef
103.
Lim YC, Song MH, Kim SC, Kim KM, Choi EC (2004) Preserving level IIb lymph nodes in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:1088–1091PubMedCrossRef
104.
Elsheikh MN, Mahfouz ME, Elsheikh E (2005) Level IIb lymph nodes metastasis in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: a molecular-based study. Laryngoscope 115:1636–1640PubMedCrossRef
105.
Bolzoni Villaret A, Piazza C, Peretti G, Calabrese L, Ansarin M, Chiesa F, Pellini R, Spriano G, Nicolai P (2007) Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg 133:897–903CrossRef
106.
Paleri V, Kumar Subramaniam S, Oozeer N, Rees G, Krishnan S (2008) Dissection of the submuscular recess (sublevel IIb) in squamous cell cancer of the upper aerodigestive tract: prospective study and systematic review of the literature. Head Neck 30:194–200PubMedCrossRef
107.
Ferlito A, Silver CE, Suárez C, Rinaldo A (2007) Preliminary multi-institutional prospective pathologic and molecular studies support preservation of sublevel IIB and level IV for laryngeal squamous carcinoma with clinically negative neck. Eur Arch Otorhinolaryngol 264:111–114PubMedCrossRef
108.
Lea J, Bachar G, Sawka AM, Lakra DC, Gilbert RW, Irish JC, Brown DH, Gullane PJ, Goldstein DP (2010) Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Head Neck 32:184–190
109.
Ferlito A, Silver CE, Rinaldo A (2009) Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg 47:5–9PubMedCrossRef
110.
Ferlito A, Rinaldo A, Silver CE, Gourin CG, Shah JP, Clayman GL, Kowalski LP, Shaha AR, Robbins KT, Suárez C, Leemans CR, Ambrosch P, Medina JE, Weber RS, Genden EM, Pellitteri PK, Werner JA, Myers EN (2006) Elective and therapeutic selective neck dissection. Oral Oncol 42:14–25PubMedCrossRef
111.
Patel RS, Clark JR, Gao K, O’Brien CJ (2008) Effectiveness of selective neck dissection in the treatment of the clinically positive neck. Head Neck 30:1231–1236PubMedCrossRef
112.
Stoeckli SJ, Alkureishi LW, Ross GL (2009) Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 266:787–793PubMedCrossRef
113.
Stoeckli SJ (2007) Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Laryngoscope 117:1539–1551PubMedCrossRef
114.
Stoeckli SJ, Steinert H, Pfaltz M, Schmid S (2001) Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 125:221–226PubMedCrossRef
115.
Shoaib T, Soutar DS, Prosser JE, Dunaway DJ, Gray HW, McCurrach GM, Bessent RG, Robertson AG, Oliver R, MacDonald DG (1999) A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck. Head Neck 21:728–733PubMedCrossRef
116.
Civantos FJ, Zitsch R, Schuller D, Agrawal A, Smith R, Nason R, Petruzelli G, Gourin C, Yarbrough W, Myers J (2006) Sentinel lymph node biopsy for oral cancer: a multi-institutional validation trial. Arch Otolaryngol Head Neck Surg 132:839–840CrossRef
117.
Ross GL, Soutar DS, MacDonald DG, Shoaib T, Camilleri I, Roberton AG, Sorensen JA, Thomsen J, Grupe P, Alvarez J, Barbier L, Santamaria J, Poli T, Massarelli O, Sesenna E, Kovács AF, Grünwald F, Barzan L, Sulfaro S, Alberti F (2004) Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 11:690–696PubMedCrossRef
118.
Civantos FJ (2010) Sentinel lymph node biopsy for head and neck cancer. In: Ferlito A, Robbins KT, Silver CE (eds) Neck dissection—management of regional disease in head and neck cancer. Plural Publishing, San Diego, pp 81–95
119.
Ross GL, Soutar DS, Shoaib T, Sato E, Hyodo I, Ogawa T, Nakashima T, Yatabe Y (2002) The ability of lymphoscintigraphy to direct sentinel node biopsy in the clinically N0 neck for patients with head and neck squamous cell carcinoma. Br J Radiol 75:950–958PubMed
120.
Longnecker SM, Guzzardo MM, Van Voris LP (1985) Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm 4:219–221PubMed
121.
Terada A, Hasegawa Y, Goto M, Sato E, Hyodo I, Ogawa T, Nakashima T, Yatabe Y (2006) Sentinel lymph node radiolocalization in clinically negative neck oral cancer. Head Neck 28:114–120PubMedCrossRef
122.
Tschopp L, Nuyens M, Stauffer E, Krause T, Zbären P (2005) The value of frozen section analysis of the sentinel lymph node in clinically N0 squamous cell carcinoma of the oral cavity and oropharynx. Otolaryngol Head Neck Surg 132:99–102PubMedCrossRef
123.
Stoeckli SJ, Pfaltz M, Ross GL, Steiner HC, MacDonald DG, Wittekind C, Soutar DS (2005) The second international conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol 12:919–924PubMedCrossRef
124.
Ross G, Shoaib T, Soutar DS, Camilleri IG, Gray HW, Bessent RG, Robertson AG, MacDonald DG (2002) The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 128:1287–1291PubMed
125.
Paleri V, Rees G, Arullendran P, Shoaib T, Krishman S (2005) Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 27:739–747PubMedCrossRef
126.
Devaney KO, Rinaldo A, Rodrigo JP, Ferlito A (2006) Sentinel node biopsy and head and neck tumors: where do we stand today? Head Neck 28:1122–1131PubMedCrossRef
127.
Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhoff RH, van der Waal I, Snow GB, Leemans CR (2002) Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 24:282–289PubMedCrossRef
128.
van der Haring IS, Schaapveld MS, Roodenburg JL, de Bock GH (2009) Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method. Int J Oral Maxillofac Surg 38:332–338PubMedCrossRef
Metadata
Title
Contemporary management of cancer of the oral cavity
Authors
Eric M. Genden
Alfio Ferlito
Carl E. Silver
Robert P. Takes
Carlos Suárez
Randall P. Owen
Missak Haigentz Jr.
Sandro J. Stoeckli
Ashok R. Shaha
Alexander D. Rapidis
Juan Pablo Rodrigo
Alessandra Rinaldo
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 7/2010
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1206-2

Other articles of this Issue 7/2010

European Archives of Oto-Rhino-Laryngology 7/2010 Go to the issue

Rhinology

Differential rates of proliferation and apoptosis in nasal polyps correspond to alterations in DNA spatial distribution and nuclear polarization as observed by confocal microscopy

Otology

Functional results of 394 bilateral stapedotomies evaluated with the Glasgow Benefit Plot

Head and Neck

Self-expanding metal stents in palliation of malignant dysphagia: outcome of 124 Egyptian patients

Case Report

Recurrent well-differentiated liposarcoma of the larynx: a case report and review of literature

Otology

Ear-pick injury as a traumatic ossicular damage in Japan

Editorial

Is it necessary to perform radical neck dissection as a salvage procedure for persistent or recurrent neck disease after chemoradiotherapy in patients with nasopharyngeal cancer?